At New York’s latest Cannabis Control Board meeting, applicants learned they may wait until 2033 for license approval—fueling outrage as new marketing rules roll out and thousands remain stuck in regulatory limbo.
Thailand's cannabis U-turn has upended an entire industry. As new laws push the plant into strict medical control, small businesses and farmers struggle—while clinics and corporate growers gain ground. What does this mean for the future of cannabis in Asia?
Thailand’s $1.2B cannabis market is reeling as 90% of dispensaries are shut down and the government moves to reclassify the plant as a narcotic. Some say it’s chaos—others call it a necessary reset.
A new Bloomwell survey reveals 42% of German cannabis patients would return to illicit sources if digital access is restricted. With patient numbers up 1100% since reclassification, leaders warn that political rollbacks could reverse medical progress.
A new House GOP spending bill seeks to halt cannabis rescheduling, threatening federal reform progress even as support grows among Republicans and youth voters.
Florida’s adult-use cannabis campaign is gaining momentum, but a new law signed by Governor DeSantis revokes medical marijuana cards from patients with drug convictions—signaling a sharp crackdown even as legalization efforts ramp up for 2026.
Thailand has ended its brief era of cannabis decriminalization, banning recreational use and requiring medical prescriptions. The abrupt reversal shakes a $1.2B industry and sparks protests as political turmoil deepens and dispensaries face closures.
Czechia will legalize home cannabis cultivation and possession for adults 21+ starting January 1, 2026. The law allows up to 3 plants and 100g of flower, marking a major shift in European drug policy—though retail sales remain off the table for now.
PHCANN CEO Sasho Stefanoski shares how he scaled Europe’s largest medical supply chain, from a high-tech facility in Macedonia to partnerships with Tyson 2.0 and global markets like Germany, Poland, the UK, and Australia.
TerrAscend expands into its sixth U.S. state with the acquisition of Ratio Cannabis in Ohio. The move adds a high-performing dispensary to its 39-location footprint and positions the company for growth ahead of the state's adult-use market launch.
Jeff Schultz, a former hedge fund attorney, has become a leading voice in cannabis law and policy. From shaping New York’s adult-use rollout to advising top brands, his journey reflects the power of passion, advocacy, and legal expertise in a shifting industry.
New York’s cannabis market hits new highs with 366 dispensaries, workforce training programs, and a statewide education campaign. OCM leads with equity, safety, and science to grow a smarter, more inclusive industry.
The U.S. legal cannabis market is projected to add $123.6 billion to the economy in 2025, despite stalled reform and rising costs. With New York and Ohio emerging and federal change on pause, the industry grows through uncertainty. What will it take to unlock its full potential?
Germany will maintain its cannabis legalization law despite conservative opposition, with a full policy review set for late 2025. Personal use and cultivation remain legal, while medical access and cannabis clubs continue under national guidelines.
The 2025 International Cannabis Business Conference (ICBC) in Berlin marks a decade of industry progress, spotlighting Germany’s landmark cannabis legalization. With Germany leading Europe in medical cannabis reform, ICBC serves as a key platform for global cannabis policy, business, and advocacy.
